Oldal 103 [103]
REFERENCES ® 101
Meshack, A., Peters, R. J., Jr., Lin, M.-T., Hill, M., Abughosh, S., & Essien, E. J. (2013).
The beliefs of teenage male cannabinoid users: a qualitative study. American Jour¬
nal of Health Studies, 28(3), 109-113.
Miller, G. D., & Baldwin, J. D. C. (1987). Implications of the wounded-healer para¬
digm for the use of the self in therapy. Journal of Psychotherapy & the Family, 3(1),
139-151.
Milligan, D., McCarthy-Jones, S., Winthrop, A., & Dudley, R. (2012). Time changes
everything? A qualitative investigation of the experience of auditory verbal hal¬
lucinations over time. Psychosis, 5(2), 107-118. doi: 10.1080/17522439.2012.667438
Milligan, D., McCarthy-Jones, S., Winthrop, A., & Dudley, R. (2013). Time changes
everything? A qualitative investigation of the experience of auditory verbal hal¬
lucinations over time. Psychosis, 5(2), 107-118. doi: 10.1080/17522439.2012.667438
Mord, L., & Racz, J. (2013). Online drug user-led harm reduction in Hungary: a review
of “Daath”. Harm Reduction Journal, 10(1), 18.
Müller, Kornhuber, J., & Sperling, W. (2015). The behavioral profile of spice and
synthetic cannabinoids in humans. Brain Research Bulletin. doi: 10.1016/j.brain¬
resbull.2015.10.013
Müller, Sperling, W., Köhrmann, M., Huttner, B. H., Kornhuber, J., & Maler, J. M. (2010).
The synthetic cannabinoid Spice as a trigger for an acute exacerbation of cannabis
induced recurrent psychotic episodes. Schizophrenia Research, 118, 309-310.
Nacca, N., Vatti, D., Sullivan, R., Sud, P, Su, M., & Marraffa, J. (2013). The synthetic
cannabinoid withdrawal syndrome. Journal of Addiction Medicine, 7(4), 296-298.
doi: 10.1097/ADM.0b013e31828e1881
Nagy, Z. (2015). *..életiink minden megnyilvanuldsdban.” A felépiilés életrendje és
értékrendje 12 lépéses programokban józanodó szerfüggők körében. Eötvös Lóránd
University, Budapest.
Nakajima, J. i., Takahashi, M., Seto, T., Kanai, C., Suzuki, J., Yoshida, M., . . . Hamano,
T. (2013). Analysis of azepane isomers of AM-2233 and AM-1220, and detection
of an inhibitor of fatty acid amide hydrolase [3'-(aminocarbonyl)(1, 1'-biphenyl)¬
3-yl]-cyclohexylcarbamate (URB597) obtained as designer drugs in the Tokyo
area. Forensic Toxicology, 31(1), 76-85.
National Institute of Mental Health. Questions and answears about psychosis. Re¬
trieved 26-01-2019, from https://www.nimh.nih.gov/health/topics/schizophrenia/
raise/raise-questions-and-answers.shtml#1
Newton, E., Larkin, M., Melhuish, R., & Wykes, T. (2007). More than just a place to
talk: Young people’s experiences of group psychological therapy as an early inter¬
vention for auditory hallucinations. Psychology and Psychotherapy: Theory, Re¬
search and Practice, 80(1), 127-149. doi: 10.1348/147608306X110148
Nuevo, R., Chatterji, S., Verdes, E., Naidoo, N., Arango, C., & Ayuso Mateos, J. L. (2012).
The continuum of psychotic symptoms in the general population: a cross-national
study. Schizophrenia Bulletin, 38(475-485). doi: doi: 10.1093/schbul/sbq099